195 related articles for article (PubMed ID: 28154663)
1. Pulmonary alveolar hemorrhage mimicking a pneumopathy: a rare complication of dual antiplatelet therapy for ST elevation myocardial infarction.
Oualim S; Elharda CA; Benzeroual D; Hattaoui ME
Pan Afr Med J; 2016; 24():308. PubMed ID: 28154663
[TBL] [Abstract][Full Text] [Related]
2. Diffuse alveolar hemorrhage as a complication of dual antiplatelet therapy for acute coronary syndrome.
Ikeda M; Tanaka H; Sadamatsu K
Cardiovasc Revasc Med; 2011; 12(6):407-11. PubMed ID: 21514251
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Triple Antiplatelet Therapy Including Cilostazol in Elderly Patients with ST-Elevation Myocardial Infarction who Underwent Primary Percutaneous Coronary Intervention: Results from the INTERSTELLAR Registry.
Jang HJ; Park SD; Park HW; Suh J; Oh PC; Moon J; Lee K; Kang WC; Kwon SW; Kim TH
Drugs Aging; 2017 Jun; 34(6):467-477. PubMed ID: 28456945
[TBL] [Abstract][Full Text] [Related]
4. Platelet function testing guided antiplatelet therapy reduces cardiovascular events in Chinese patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: The PATROL study.
You J; Li H; Guo W; Li J; Gao L; Wang Y; Geng L; Wang X; Wan Q; Zhang Q
Catheter Cardiovasc Interv; 2020 Feb; 95 Suppl 1():598-605. PubMed ID: 31957972
[TBL] [Abstract][Full Text] [Related]
5. MULTInational non-interventional study of patients with ST-segment elevation myocardial infarction treated with PRimary Angioplasty and Concomitant use of upstream antiplatelet therapy with prasugrel or clopidogrel--the European MULTIPRAC Registry.
Clemmensen P; Grieco N; Ince H; Danchin N; Goedicke J; Ramos Y; Schmitt J; Goldstein P;
Eur Heart J Acute Cardiovasc Care; 2015 Jun; 4(3):220-9. PubMed ID: 25182465
[TBL] [Abstract][Full Text] [Related]
6. Effect of a combination of antiplatelet and antithrombotic pretreatment on myocardial perfusion in patients with an acute ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
Prech M; Bartela E; Janus M; Jeremicz I; Araszkiewicz A; Urbanska L; Pyda M; Grajek S
Coron Artery Dis; 2016 Nov; 27(7):580-5. PubMed ID: 27228184
[TBL] [Abstract][Full Text] [Related]
7. Short-term follow-up of tirofiban as alternative therapy for urgent surgery patients with an implanted coronary drug-eluting stent after ST-elevation myocardial infarction.
Xia JG; Qu Y; Shen H; Liu XH
Coron Artery Dis; 2013 Sep; 24(6):522-6. PubMed ID: 23900046
[TBL] [Abstract][Full Text] [Related]
8. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
[TBL] [Abstract][Full Text] [Related]
9. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial.
Aronow HD; Steinhubl SR; Brennan DM; Berger PB; Topol EJ;
Am Heart J; 2009 Feb; 157(2):369-74. PubMed ID: 19185647
[TBL] [Abstract][Full Text] [Related]
10. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study.
Lamberts M; Olesen JB; Ruwald MH; Hansen CM; Karasoy D; Kristensen SL; Køber L; Torp-Pedersen C; Gislason GH; Hansen ML
Circulation; 2012 Sep; 126(10):1185-93. PubMed ID: 22869839
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
Yu J; Mehran R; Baber U; Ooi SY; Witzenbichler B; Weisz G; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Brodie BR; Stuckey TD; Maehara A; Xu K; Ben-Yehuda O; Kirtane AJ; Stone GW
Circ Cardiovasc Interv; 2017 Feb; 10(2):. PubMed ID: 28193677
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Average Daily Ischemic and Bleeding Risk After Primary PCI for STEMI.
Giustino G; Mehran R; Dangas GD; Kirtane AJ; Redfors B; Généreux P; Brener SJ; Prats J; Pocock SJ; Deliargyris EN; Stone GW
J Am Coll Cardiol; 2017 Oct; 70(15):1846-1857. PubMed ID: 28982497
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based oral antiplatelet therapy among hospitalized Chinese patients with acute myocardial infarction: results from the Chinese acute myocardial infarction registry.
Tang X; Liu L; Yang J; Gao Z; Zhao X; Qiao S; Gao R; Wang Z; Yuan J; Yang Y
BMC Cardiovasc Disord; 2021 Jun; 21(1):299. PubMed ID: 34126921
[TBL] [Abstract][Full Text] [Related]
15. Normal chest radiograph and ground glass opacities on a thoracic computed tomographic scan in a patient with diffuse alveolar haemorrhage due to dual antiplatelet therapy prescribed after patent foramen ovale percutaneous device closure.
Kalinczuk L; Lubiszewska B; Demkow M
Eur Heart J; 2011 Dec; 32(23):2988. PubMed ID: 21893488
[No Abstract] [Full Text] [Related]
16. Short-term efficacy and safety of three different antiplatelet regimens in diabetic patients treated with primary percutaneous coronary intervention: a randomised study.
Liu Y; Liu H; Hao Y; Hao Z; Geng G; Han W; Chen Q; Wang D; Liu L; Jia K; Zhou Y
Kardiol Pol; 2017; 75(9):850-858. PubMed ID: 28612911
[TBL] [Abstract][Full Text] [Related]
17. Pre-treatment with dual antiplatelet therapy in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention.
Yudi MB; Eccleston D; Andrianopoulos N; Farouque O; Duffy SJ; Brennan A; Reid C; Clark DJ; Ajani AE;
Intern Med J; 2015 Oct; 45(10):1032-7. PubMed ID: 26013065
[TBL] [Abstract][Full Text] [Related]
18. Extended Duration Dual Antiplatelet Therapy After Coronary Stenting Among Patients With Peripheral Arterial Disease: A Subanalysis of the Dual Antiplatelet Therapy Study.
Secemsky EA; Yeh RW; Kereiakes DJ; Cutlip DE; Steg PG; Massaro JM; Apruzzese PK; Mauri L;
JACC Cardiovasc Interv; 2017 May; 10(9):942-954. PubMed ID: 28473118
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Alveolar Hemorrhage after Clopidogrel Use for ST Elevation Myocardial Infarction.
Kim Y; Lim J; Lim J; Kim S; Jung T; Choi W
Korean Circ J; 2013 Jul; 43(7):497-9. PubMed ID: 23964298
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention Receiving an Oral Anticoagulant and Dual Antiplatelet Therapy: A Comparison of Clopidogrel Versus Prasugrel From the TRANSLATE-ACS Study.
Jackson LR; Ju C; Zettler M; Messenger JC; Cohen DJ; Stone GW; Baker BA; Effron M; Peterson ED; Wang TY
JACC Cardiovasc Interv; 2015 Dec; 8(14):1880-9. PubMed ID: 26718518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]